NCT01031069 2020-07-21Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected FemalesGlaxoSmithKlinePhase 4 Completed873 enrolled 34 charts